Aripiprazole Treatment of Prodromal Patients

Aripiprazole Treatment of Prodromal Patients

We hypothesize that symptoms will improve in patients who meet diagnostic criteria for the schizophrenia prodrome when they are prescribed aripiprazole.

This is an 8 week trial with extension for responders out to one year. All patients receive active medication; there is no placebo. Patients must meet criteria for the schizophrenia prodrome according to the Structured Interview for Prodromal Syndromes. Patients receive counseling as well. All counseling and medication are free of charge.

Inclusion Criteria:

• age 13 to 40 meet criteria for the prodrome for schizophrenia

Exclusion Criteria:

• history of psychosis